Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 19124Generated: October 29, 2026

Diisopropylethylamine → (S)-2-[4-(2,6-difluoro-3-methoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-yl]-amide

https://huagongshe.com/reaction/19124

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
ReactantBenzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 151348—
Reactant(R)-1-((2,2-Dimethyl-1,3-dioxolan-4-yl)methyl)-1H-pyrazol-3-amineHCID 59344941—
Reactant(S)-2-[4-(2,6-difluoro-3-methoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acidHCID 66894950—
SolventDimethylformamideHCID 6228—
Product(S)-2-[4-(2,6-difluoro-3-methoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-yl]-amideHCID 5792009564.5%

Reaction Conditions

Temperature0 °C

Reaction Steps

To a solution of (S)-2-[4-(2,6-difluoro-3-methoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid (0.200 g, 0.56 mmol) in N,N-dimethylformamide (7 mL) was added 1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-ylamine (prepared as in Example 49, 0.139 g, 0.70 mmol) and benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (0.374 g, 0.85 mmol). The mixture was stirred at 0° C. and N,N-diisopropylethylamine (0.193 g, 1.49 mmol) was added. The mixture was stirred at room temperature overnight and the solvents were evaporated. The residue was treated with ethyl acetate and ammonium chloride solution, and the organic layer separated. The organic layer was washed with brine and dried over sodium sulfate. The solvents were evaporated and the residue was purified by ISCO flash chromatography (Teledyne Isco RediSep Flash Column 40 g, 50% to 90% ethyl acetate/hexanes) which afforded (S)-2-[4-(2,6-difluoro-3-methoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-yl]-amide (0.193 g, 64%) as a pale brown solid: HR-ES-MS m/z calculated for C26H32F2N4O6 [M+H]+ 535.2363, observed 535.2363, 1H NMR (300 MHz, DMSO-d6) δ ppm 1.00 0.90 (d, J=6.3 Hz, 3H), 0.93 (d, J=6.3 Hz, 3H), 1.25 (s, 3H), 1.30 (s, 3 H), 1.36-1.50 (m, 1H), 1.50-1.65 (m, 1H), 1.69-1.84 (m, 1H), 3.73 (dd, J=8.4, 5.7 Hz, 1H), 3.87 (s, 3H), 4.00 (dd, J=8.4, 6.5 Hz, 1H), 4.11 (t, J=5.4 Hz, 2H), 4.27 (d, J=18.7 Hz, 1H), 4.35 (t, J=5.7 Hz, 1H), 4.62 (d, J=18.7 Hz, 1H), 4.88 (dd, J=10.6, 4.8 Hz, 1H), 5.06 (s, 1H), 6.43 (d, J=2.1 Hz, 1H), 7.18 (td, J=9.3, 5.1 Hz, 1H), 7.30 (td, J=9.5, 1.8 Hz, 1H), 7.60 (d, J=2.1 Hz, 1H), 10.82 (s, 1H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07741327B2
Source datasetuspto-grants-2010_06
ORD IDord-d9de7ff450fb4f3eb49b6a8b74dcd756
Source noteuspto-grants-2010_06